Evidence map›Paper›PMID 34358529›Full record

ArticleThe Journal of investigative dermatology2022

Epigenetic Regulation of Apoptosis in Cutaneous T-Cell Lymphoma: Implications for Therapy with Methotrexate, Jak Inhibitors, and Resveratrol.

Minakshi Nihal, Jianqiang Wu, Connor J Stonesifer, Jay Daniels, Jaehyuk Choi, Larisa Geskin, Alain H Rook, Gary S Wood

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Minakshi NihalDepartment of Dermatology, The School of Medicine and Public Health, University of Wisconsin and William S. Middleton VAMC, Madison, Wisconsin, USA. Electronic address: mnihal@dermatology.wisc.edu.
Jianqiang WuDepartment of Dermatology, The School of Medicine and Public Health, University of Wisconsin and William S. Middleton VAMC, Madison, Wisconsin, USA.
Connor J StonesiferDepartment of Dermatology, Irving Medical Center, Columbia University, New York, New York, USA.
Jay DanielsDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Jaehyuk ChoiDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Larisa GeskinDepartment of Dermatology, Irving Medical Center, Columbia University, New York, New York, USA.
Alain H RookDepartment of Dermatology, Penn Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Gary S WoodDepartment of Dermatology, The School of Medicine and Public Health, University of Wisconsin and William S. Middleton VAMC, Madison, Wisconsin, USA.
William S. Middleton Memorial Veterans Hospital · USColumbia University Irving Medical Center · USNorthwestern University · USUniversity of Pennsylvania Health System · US

Funding

CARCINOGENESIS TRAINING PROGRAMT32CA009560 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Kathleen Janee Green · 1986 to 2026
$8.4M
Skin Diseases Research Center at the University of WisconsinP30AR066524 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI LONGLEY, B JACK · 2014 to 2018
$2.6M
Dissecting mechanisms by which PD1 deletions drive aggressive cutaneous T cell lymphomaF30CA265107 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DANIELS, JAY · 2021 to 2021
$41k
FAS Pathway Abnormalities in MF and SSI01BX002204 · VA · WM S. MIDDLETON MEMORIAL VETERANS HOSP · PI WOOD, GARY S · 2015 to 2018
–
BLRD VA I01 BX002204NCI NIH HHS F30 CA265107NCI NIH HHS T32 CA009560NIAMS NIH HHS P30 AR066524
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcetylationAntineoplastic Combined Chemotherapy ProtocolsApoptosisEpigenesis, GeneticGene Expression Regulation, NeoplasticHumansJanus Kinase InhibitorsLymphoma, T-Cell, CutaneousMethotrexateProtein Processing, Post-TranslationalResveratrolSkin NeoplasmsJanus Kinase InhibitorsMethotrexateResveratrol

Identifiers

PMID34358529
PMCPMC9017049
OpenAlexW3193270512

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.